📰 Neuraxis Inc News
Page 2 - Neuraxis Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neuraxis Inc. Real-time updates on events, politics, business and more.
April 1, 2024
CARMEL, Ind., April 01, 2024 -- NeurAxis, Inc. , a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will...
March 29, 2024
NeurAxis (NASDAQ:NRXS – Get Free Report) and Edap Tms (NASDAQ:EDAP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Profitability This table compares NeurAxis and Edap Tms’ […]
March 11, 2024
CARMEL, Ind., March 11, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology compa...
February 27, 2024
CARMEL, Ind., Feb. 27, 2024 -- NeurAxis, Inc. , , a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults,...
January 1, 2024
Outset Medical (NASDAQ:OM – Get Free Report) and NeurAxis (NASDAQ:NRXS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Profitability This table compares Outset Medical and NeurAxis’ […]
January 1, 2024
NeurAxis (NASDAQ:NRXS – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 11.8% of NeurAxis shares […]
December 27, 2023
NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report) shares shot up 12% during mid-day trading on Tuesday . The stock traded as high as $3.12 and last traded at $2.52. 28,566 shares traded hands during mid-day trading, a decline of 20% from the average session volume of 35,923 shares. The stock had previously closed at $2.25. […]
December 20, 2023
CARMEL, Ind., Dec. 20, 2023 -- NeurAxis, Inc. , a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults,...
December 18, 2023
NeurAxis (NASDAQ:NRXS – Get Free Report) and Semler Scientific (NASDAQ:SMLR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk. Analyst Ratings This is a summary of recent […]
November 21, 2023
CARMEL, Ind., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company...